Intravenous meloxicam for the treatment of moderate to severe acute pain: a pooled analysis of safety and opioid-reducing effects
Eugene R. Viscusi(Thomas Jefferson University), Sue Hobson, Neil Singla(Huntington Hospital), Stewart W. McCallum(Harvard University), Tong J. Gan(The University of Texas MD Anderson Cancer Center), Randall J. Mack, Wei Du(Cubist Pharmaceuticals (United States)), Sergio D. Bergese(Stony Brook University Hospital)
Cited by 7
Related Papers
Poorly controlled postoperative pain: prevalence, consequences, and prevention
|Journal of Pain Research|2017|1.4k
Consensus Guidelines for Managing Postoperative Nausea and Vomiting
|Anesthesia & Analgesia|2003|967
Society for Ambulatory Anesthesia Guidelines for the Management of Postoperative Nausea and Vomiting
|Anesthesia & Analgesia|2007|714
Perioperative Quality Initiative consensus statement on intraoperative blood pressure, risk and outcomes for elective surgery
|British Journal of Anaesthesia|2019|659